Aerosolized antibiotics: do they add to the treatment of pneumonia?

PURPOSE OF REVIEW: The increasing rate of ventilator-associated pneumonia (VAP) caused by multidrug-resistant pathogens warrants the development of new treatment strategies. Carefully engineered delivery systems are undergoing evaluation to test the hypothesis that aerosolized administration of anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollef, Marin H., Hamilton, Cindy W., Montgomery, A. Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2013
Materias:
ANTIMICROBIAL AGENTS: Edited by Monica A. Slavin and Deenan Pillay
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814630/
https://www.ncbi.nlm.nih.gov/pubmed/24126716
http://dx.doi.org/10.1097/QCO.0000000000000004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814630/
https://www.ncbi.nlm.nih.gov/pubmed/24126716
http://dx.doi.org/10.1097/QCO.0000000000000004

Ejemplares similares